**Core Concept**
The question is testing the knowledge of appropriate neuromuscular blocking agents for rapid sequence induction (RSI) in scenarios where succinylcholine is contraindicated. Succinylcholine is a depolarizing neuromuscular blocker commonly used for RSI, but it has contraindications such as hyperkalemia, burns, and neuromuscular disorders.

**Why the Correct Answer is Right**
In such scenarios, non-depolarizing neuromuscular blockers (NDNMBs) are preferred. **Rocuronium** is a rapid-onset NDNMB that can be used for RSI in place of succinylcholine. It has a faster onset of action compared to other NDNMBs like vecuronium or atracurium, making it suitable for RSI. Rocuronium works by competitively blocking the nicotinic acetylcholine receptors at the neuromuscular junction, preventing acetylcholine from binding and causing muscle contraction.

**Why Each Wrong Option is Incorrect**
* **Option A:** Vecuronium, while an NDNMB, has a slower onset of action compared to rocuronium and is not the preferred choice for RSI.
* **Option B:** Atracurium, another NDNMB, has a slower onset of action and is more commonly used for maintenance of neuromuscular blockade rather than RSI.
* **Option D:** Cisatracurium, a variant of atracurium, also has a slower onset of action and is not typically used for RSI.

**Clinical Pearl / High-Yield Fact**
When choosing a neuromuscular blocker for RSI, consider the patient's underlying condition, the need for rapid onset of action, and the potential for side effects. Always verify the patient's medical history for contraindications to succinylcholine before administering it.

**Correct Answer:** C. Rocuronium